{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Stillwater",
      "address_1": "1951 Northwestern Ave S",
      "reason_for_recall": "Instability in the PRO-Trac II Tacrolimus ELISA kit which may cause falsely elevated patient results.",
      "address_2": "",
      "product_quantity": "451 kits",
      "code_info": "131716, 131716A, 131716B, 131716C, 131716D, 131716E,   131717.",
      "center_classification_date": "20150420",
      "distribution_pattern": "Worldwide Distribution - US in the state of CA and the countries of: CHINA, BELGIUM, ARGENTINA, and INDIA.",
      "state": "MN",
      "product_description": "DiaSorin, PRO-Trac II Tacrolimus ELISA kit, REF 32400 and 32400-CN.  Product Usage:  The PRO-Trac II Tacrolimus ELISA kit is an in vitro reagent system intended for the quantitative determination of tacrolimus (Prografl, FK506) and some metabolites in human EDT A or heparinized whole blood as an aid in the management of liver transplant patients receiving tacrolimus therapy.",
      "report_date": "20150429",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Diasorin Inc.",
      "recall_number": "Z-1464-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "70773",
      "termination_date": "20150915",
      "more_code_info": "",
      "recall_initiation_date": "20150316",
      "postal_code": "55082-7536",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}